Lund, Sweden — Camurus AB (Nasdaq Stockholm; CAMX) today announces that they are hosting a Capital Markets and R&D Day today, 14th December in Stockholm.
Time: Wednesday 14 December, 1.30pm – 5.00pm CET
Venue: IVA Conference Center, Grev Turegatan 16, Stockholm
Invitation for: Institutional investors, analysts and media
The videotaped presentations from the Capital Markets and R&D Day will be posted on www.financialhearings.com during the afternoon Thursday 15 December.
Slide sets from the Capital Markets and R&D Day will be available the company web-site www.camurus.com.
For more information please contact:
ir@camurus.com
About Camurus
Camurus is a Swedish research-based pharmaceutical company committed to developing and commercializing innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the proprietary FluidCrystal® drug delivery technologies and an extensive R&D expertise. Camurus’ clinical pipeline includes products for treatment of cancer, endocrine diseases, pain and addiction, developed in-house and in collaboration with international pharmaceutical companies. The company’s shares are listed on Nasdaq Stockholm under the ticker “CAMX”. For more information, visit www.camurus.com
The information was submitted for publication at 10.00 a.m. CET on 14 December 2016.